Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Lansoprazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lansoprazole and what is the scope of lansoprazole freedom to operate?

is the generic ingredient in seven branded drugs marketed by Labs Liconsa, Natco Pharma Ltd, Takeda Pharms Usa, Sun Pharm Inds Ltd, Krka Tovarna Zdravil, Perrigo R And D, Dexcel Pharma, Wockhardt Ltd, Glaxosmithkline Cons, Ani Pharms Inc, Sandoz, Teva Pharms, Ajanta Pharma Ltd, Mylan Pharms Inc, Zydus Hlthcare, Takeda Pharms Na, Dr Reddys Labs Ltd, and Wockhardt Usa, and is included in twenty-five NDAs. There are six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Lansoprazole has fifty-four patent family members in nineteen countries.

There are fifty-four drug master file entries for lansoprazole. Eighty-six suppliers are listed for this compound.

Summary for Generic Name: lansoprazole

Drug Master File Entries: see list54
Suppliers / Packagers: see list86
Bulk Api Vendors: see list81
Clinical Trials: see list47
Patent Applications: see list6,423
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:lansoprazole at DailyMed

Pharmacology for Ingredient: lansoprazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa
TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING;ORAL021428-001Aug 30, 2002RXYesNo7,399,485*PED► SubscribeY► Subscribe
Mylan Pharms Inc
CAPSULE, DELAYED REL PELLETS;ORAL203187-001Jun 1, 2016OTCNoNo► Subscribe► Subscribe
Natco Pharma Ltd
CAPSULE, DELAYED REL PELLETS;ORAL201921-001Dec 18, 2012ABRXNoNo► Subscribe► Subscribe
Natco Pharma Ltd
CAPSULE, DELAYED REL PELLETS;ORAL203306-001Jan 13, 2016OTCNoNo► Subscribe► Subscribe
Takeda Pharms Na
FOR SUSPENSION, DELAYED RELEASE;ORAL021281-002May 3, 2001DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus